Bertelsen, Natasha
Landi, Isotta
Bethlehem, Richard A. I. http://orcid.org/0000-0002-0714-0685
Seidlitz, Jakob http://orcid.org/0000-0002-8164-7476
Busuoli, Elena Maria
Mandelli, Veronica
Satta, Eleonora
Trakoshis, Stavros
Auyeung, Bonnie
Kundu, Prantik
Loth, Eva
Dumas, Guillaume
Baumeister, Sarah
Beckmann, Christian F.
Bölte, Sven
Bourgeron, Thomas http://orcid.org/0000-0001-8164-9220
Charman, Tony http://orcid.org/0000-0003-1993-6549
Durston, Sarah
Ecker, Christine
Holt, Rosemary J.
Johnson, Mark H.
Jones, Emily J. H.
Mason, Luke
Meyer-Lindenberg, Andreas
Moessnang, Carolin
Oldehinkel, Marianne
Persico, Antonio M. http://orcid.org/0000-0001-8910-4479
Tillmann, Julian
Williams, Steve C. R.
Spooren, Will
Murphy, Declan G. M.
Buitelaar, Jan K.
,
Ahmad, Jumana
Ambrosino, Sara
Banaschewski, Tobias
Bours, Carsten
Brammer, Michael
Brandeis, Daniel
Brogna, Claudia
de Bruijn, Yvette
Chakrabarti, Bhismadev
Chatham, Chris
Cornelissen, Ineke
Crawley, Daisy
Dell’Acqua, Flavio
Faulkner, Jessica
Frouin, Vincent
Garcés, Pilar
Goyard, David
Ham, Lindsay
Hayward, Hannah
Hipp, Joerg
Holt, Rosemary J.
D’ardhuy, Xavier Liogier
Lythgoe, David J.
Mandl, René
Marquand, Andre
Mennes, Maarten
Mueller, Nico
Oakley, Bethany
O’Dwyer, Laurence
Oranje, Bob
Pandina, Gahan
Persico, Antonio M.
Ruggeri, Barbara
Ruigrok, Amber N. V.
Sabet, Jessica
Sacco, Roberto
Cáceres, Antonia San José
Simonoff, Emily
Toro, Roberto
Tost, Heike
Waldman, Jack
Williams, Steve C. R.
Wooldridge, Caroline
Zwiers, Marcel P.
Baron-Cohen, Simon
Lai, Meng-Chuan
Lombardo, Michael V. http://orcid.org/0000-0001-6780-8619
Article History
Received: 4 November 2020
Accepted: 23 March 2021
First Online: 14 May 2021
Competing interests
: JKB has been a consultant to, advisory board member of, and a speaker for Janssen Cilag BV, Eli Lilly, Shire, Lundbeck, Roche, and Servier. He is not an employee of any of these companies and not a stock shareholder of any of these companies. He has no other financial or material support, including expert testimony, patents, or royalties. CFB is director and shareholder in SBGneuro Ltd. SB discloses that he has in the last 5 years acted as an author, consultant, or lecturer for Shire/Takeda, Medice, Roche, Eli Lilly, and Prima Psychiatry. He receives royalties for textbooks and diagnostic tools from Huber/Hogrefe, Kohlhammer, and UTB. TC has received consultancy from Roche and Servier and received book royalties from Guildford Press and Sage. DGMM has been a consultant to, and advisory board member, for Roche and Servier. He is not an employee of any of these companies, and not a stock shareholder of any of these companies. AML has received consultant fees from Boehringer Ingelheim, Elsevier, Brainsway, Lundbeck Int. Neuroscience Foundation, Lundbeck A/S, The Wolfson Foundation, Bloomfield Holding Ltd, Shanghai Research Center for Brain Science, Thieme Verlag, Sage Therapeutics, v Behring Röntgen Stiftung, Fondation FondaMental, Janssen-Cilag GmbH, MedinCell, Brain Mind Institute, Agence Nationale de la Recherche, CISSN (Catania Internat. Summer School of Neuroscience), Daimler und Benz Stiftung and American Association for the Advancement of Science. Additionally, he has received speaker fees from Italian Society of Biological Psychiatry, Merz-Stiftung, Forum Werkstatt Karlsruhe, Lundbeck SAS France, BAG Psychiatrie Oberbayern, Klinik für Psychiatrie und Psychotherapie Ingolstadt, med Update GmbH, Society of Biological Psychiatry and Siemens Healthineers. He is not an employee of any of these companies, and not a stock shareholder of any of these companies. JT is a consultant to Roche. All other authors declare no competing interests.